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Penicillium brasilianumAbstract Two 1,5-diaryl-3-oxo-1,4-pentadienyls (1 and 2) having nitro group attached exhibited
potent anti-parasitic activity when evaluated against Trypanosoma cruzi and Leishmania amazonen-
sis. In the present work, metabolomic analysis revealed that enzymatic action of T. cruzi reduces the
C‚C bonds and let the nitro groups intact. Further, these two reduced compounds along with six
other congeners were produced by chemical or microbiological methods and evaluated against
T. cruzi. All reduced compounds showed less potency than compounds 1 and 2, proving the impor-
tance of unsaturated moieties for activity. This investigation provides insight into the mechanism of
action of nitro unsaturated diarylpentadienones reinforcing previous studies showing their interfer-
ence in the redox metabolism of T. cruzi. In the result increase in reactive oxygen and nitrogen spe-
cies occurs, altering mitochondrial function and depleting the whole antioxidant system, which
ultimately causes parasite death. Docking studies using trypanothione oxy-reductase as target
helped understanding the activities. The present investigation confirms that enzymes play a pivotal
role in drug activation.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
According to the World Health Organization (WHO) report, the par-
asitic infections such as chagas disease and leishmaniasis still show
worrying enhancements, especially in the developing countries
(N340, 2014). The lack of safe medication and the serious side effect
caused by the use of available chemotherapy (McGreevy and Marsden,
1986), require intensive attention of the scientific community, in
attempts to develop novel drugs for the treatment of these diseases.the anti-
2 Z.U. Din et al.Recently, chalcones and related compounds emerged as a new class
of anti-trypanosomatids agents (Roussaki et al., 2013). Other classes of
compounds having nitro group have recently been revived for the
advancement into clinical trials (Marin-Neto et al., 2009; Patterson
and Wyllie, 2014; Priotto et al., 2009; Torreele et al., 2010), and many
of them are in the market serving to cure anti-parasitic diseases
(Patterson and Wyllie, 2014). It seems that nitro group in conjugation
with other structural elements significantly increases anti-parasitic
activity and yields more potent compounds (Boechat et al., 2015).
In our previous work (Zia et al., 2014), a series formed of 20 com-
pounds inspired from the natural products chalcone and curcuminoid
was synthesized and tested against Trypanosoma cruzi and Leishmania
amazonensis. Among these substances, 2-methyl-1-(4-nitrophenyl)-5-p
henylpenta-1,4-dien-3-one (1) and 2-methyl-1,5-bis(4-nitrophenyl)pen
ta-1,4-dien-3-one (2) showed impressive results, with IC50 lower than
the commercial drug benznidazole. During following studies, it was
observed that compounds 1 and 2 induce oxidative stress in three dif-
ferent forms of T. cruzi, causing damage in essential cell structures,
reflecting in lipid peroxidation and DNA fragmentation (Bido´ia
et al., 2015).
Other researchers found that the anti-mycobacterial agent PA-824,
which contains nitro group, is reduced by a deazaflavin (F420)-
dependent nitroreductase (Ddn) in Mycobacterium tuberculosis
(Singh et al., 2009) to amines. Nitroreductase (NTR) was also identi-
fied in trypanosomatid protozoa which are responsible for the activa-
tion of trypanocidal nitro compounds including Bzn, Nfx and also
fexinidazole by reductive potential of NTR1 (Hall et al., 2011;
Wilkinson et al., 2008). During similar studies, Roma˜o et al. have
shown that the antioxidant system, trypanothione/trypanothione
reductase, is involved in protecting Leishmania against the toxic effect
of nitrogen-derived reactive species (Roma˜o et al., 2006).
In the present study, efforts were made in order to gain understand-
ing in the metabolism and the structural requirements that affect activ-
ities of compounds derived from 1 and 2, as these compounds have
nitro group and electrophilic centers that may interact with co-
enzymes glutathione and trypanothione, which are part of the redox
system in these parasites. Thus we studied the metabolism of com-
pounds 1 and 2 by T. cruzi. Further, compounds 1 and 2 were reduced
by different chemo selective agent and were feed to T. cruzi to see
either the compounds are active or not. In silico investigation revealed
target systems for compounds 1 and 2.2. Results and discussion
2.1. Chemistry
2.1.1. Transformation of compounds 1 and 2 by T. cruzi
Compounds 1 and 2 were synthesized by classical acid cat-
alyzed aldol reaction of nitrobenzaldehyde with unsymmetrical
ketone (2-butanone) to yield an intermediate that was thenO
O2N R
1. R = H 
2. R = NO2 
T. cr
Figure 1 Unsymmetrical 1,5-diaryl-3-oxo-1,4-pentadienyls 1 and 2
bonds.
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presence of base to give 1 and 2. These two nitro groups con-
taining substances were very active when tested against differ-
ent forms of T. cruzi and L. amazonensis (Bido´ia et al., 2015;
Zia et al., 2014).
Metabolomic profile of these compounds by T. cruzi was
studied. Epimastigote form was exposed to 20 lM of 1 and 2
over six hours and then metabolites were extracted. After this
treatment, approximately 90% of the parasites were found
died. Parasites that were not exposed to compounds 1 and 2
were used as control for mass spectrometric analysis of both
samples in parallel with reference compounds.
Cultivation medium containing T. cruzi with and without
test substances was lyophilized prior to extraction. Extractions
were performed by partitioning with ethyl acetate after
suspending lyophilized powder in water successively at pH 7,
3 and 8, in order to cover the possibility of forming acid or
basic compounds. Biotransformation products were detected
only in the neutral extract.
Compounds 1 and 2 were consumed completely and pro-
duced metabolites 5 and 6, respectively. Compounds 1
(C18H15NO3, 293 Da) and 2 (C18H14N2O5, 338 Da) exhibited
[MH] peaks at m/z 292 and 337 in their respective APCI
mass spectrum, and showed a cinnamoyl UV absorption band
with kmax at 318 and 323 nm, respectively. In both metabolites
detected, the cinnamoyl absorption was substituted by a kmax
at 277 (metabolite 5, from 1) and 279 (metabolite 6, from 2),
and the molecular masses increased by 4 Da (m/z 296 and
341 for 5 and 6 respectively). These data in conjunction clearly
indicated reduction of the two CAC double bond (Fig. 1).
Metabolites 5 and 6 were also characterized by HRESI-MS,
showing [M+H]+ at 298.1443 (C18H20NO3, cal. 298.1443)
and 343.1301 (C18H19N2O5, cal. 343.1294) respectively.
2.1.2. Synthesis of compounds 3–10
Based on the above shown reductive biotransformation of the
active compounds by T. cruzi, a series of substances derived
from 1 and 2 was produced, all of them containing hydro-
genated positions compared with precursors. These reduced
compounds were all tested for T. cruzi inhibition. Compounds
3–10 (Fig. 2) were obtained by chemical or microbiological
methods. Hantzsch ester hydrogenation (HEH) (Martin and
List, 2006) produced compounds 3 and 4, with reduction only
at the less substituted CAC double-bound, while the whole
cells of the fungus Penicillium brasilianum reduced both
double-bounds resulting 5 and 6. Sodium borohydride was
used for carbonyl reduction (Warda and Rheea, 1989) of 1O
O2N R
5. R = H
6. R = NO2
uzi
derived metabolites. The action of parasite reduced both double
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Figure 2 Selective reduction of different groups by selective reagent and catalyst.
The structure design of biotransformed unsymmetrical nitro-contained 1,5-diaryl-3-oxo-1,4-pentadienyls 3and 2 producing the alcohols 7 and 8. When 1 and 2 were
treated with H2 on Pd/C (Aponte et al., 2008) the double
bonds and nitro groups were reduced forming compounds 9
and 10.
The synthesis and characterization of compounds 1 and 2
are reported elsewhere (Zia et al., 2014). The 1H NMR spectra
of compounds 1 and 2 show the presence of a pair of doublets
at dH 7.53 and 7.69, with a coupling constant of c.a. 16 Hz,
typical for a trans two vinylic spins system. The 13C NMR
of both compounds shows the characteristics C‚O signal at
c.a. dC 190. Compounds 3–10 show differentiation of some
of NMR signals due to reduction of unsaturated moieties by
specific reagents. The 1H NMR spectra of compounds 3 and
4 show the appearance of methylene protons at nearly dH
3.0, while disappearing CH‚CH signal at dH 7.53 confirms
the reduction of one CH‚CH selectively. The 1H NMR spec-
tra of 5 and 6 show the disappearance of two double bonds
representative signal between dH 7 and 8, while the appearance
of new methylenic signals between 2–3 ppm confirms the
reduction of both double bonds in compounds 1 and 2. The
13C NMR spectra show the disappearing of two signals
between dC 120 and 140 and the appearance of two new signals
between 30 and 40 ppm confirms the reduction of CH‚CH.
The 1H NMR spectra of compounds 7 and 8 show the appear-
ance of doublet nearly dH 4.80, proving the reduction of car-
bonyl group. The 13C NMR confirms the reduction of
carbonyl by disappearing the carbonyl signal at dC 190 and
appearing of carbinolic signal for CAOH at dC 77.0. The
1H
NMR of compounds 9 and 10 shows the disappearance of
all CH‚CH signals at dH 7.53 and 7.69, while appearing
signal between 3 and 4 ppm confirms the reduction of olefin
system. The detection of four signals in 13C NMR appearedPlease cite this article in press as: Din, Z.U. et al., The structure design of biotransform
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was observed in aromatic signals, which was due to the reduc-
tion of nitro to amino group. The Pd/C on hydrogen reduces
double bonds along with nitro groups. The structures of all
compounds were further established using UV–Vis and mass
spectrometric analysis.
2.2. Metabolism and bioactivity study
Compounds 1 and 2 showed great anti-parasitic activities
against T. cruzi and L. amazonensis (Table 1). They inhibited
epimastigote form of T. cruzi exhibiting an IC50 value (inhibi-
tory concentration for 50% of the parasites) in micro molar
concentration (Zia et al., 2014). Recently, we studied how
these drugs act in T. cruzi and found that they cause an intense
oxidative stress resulting in cell death by necrosis, autophagy
and apoptosis. It was also observed that DNA fragmentation,
intensification of lipid per oxidation, and reduction of free thi-
ols levels occurred (Bido´ia et al., 2015). In the present work we
found that T. cruzi reduces the double-bonds of the dienone
system present in 1 and 2. This finding can be close related
to the diminishing amount of free thiols groups in the parasite
cells. Thiols groups are part of important cysteine containing
co-enzymes in many organisms. Trypanothione (N1,N8-
bis(glutathionyl)spermidine or T(SH)2) is generated from glu-
tathione by trypanothione synthetase and is the major redox
mediator in T. cruzi. The enzyme containing T(SH)2 can react
with Michael acceptors such as enones and other a,b-
unsaturated carbonyl groups containing substances. The
scheme shown in Fig. 3 below could explain the observed phys-
iological effects that 1 and 2 cause in T. cruzi, as well as the
reduction of their CAC double bonds. Carbons C-1 in 1,ed unsymmetrical nitro-contained 1,5-diaryl-3-oxo-1, 4-pentadienyls for the anti-
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Figure 3 Drug covalent interaction of 1 and 2 with trypanothione and reduction by NADPH.
Table 1 Anti-parasitic and cytotoxic activity of compounds 1–10.
S. no T. cruzi epimastigote SI in epimastigotes L. amazonensis promastigotes SI in promastigotes VERO cells
IC50 (lM) IC50 (lM) CC50 (lM)
1 3.5 ± 0.4 13.5 13.4 ± 2.0 3.5 47.3 ± 4.2
2 1.8 ± 0.2 23.9 3.4 ± 0.1 10.1 43.0 ± 4.24
3 52.2 ± 1.6 4.8 6.8 ± 0.0 36.5 248.1 ± 15.3
4 11.9 ± 0.6 12.8 24.4 ± 2.4 6.3 152.7 ± 3.9
5 58.1 ± 0.9 2.4 20.2 ± 2.2 7.0 140.4 ± 5.23
6 15.3 ± 2.1 7.2 16.6 ± 1.8 6.7 110.9 ± 4.3
7 >100 – 74.0 ± 4.0 4.4 323.8 ± 13.3
8 22.4 ± 1.62 13.5 23.7 ± 2.4 12.7 302.1 ± 15.8
9 89.8 ± 6.94 3.2 21.0 ± 1.8 13.8 260.3 ± 1.3
10 42.7 ± 4.45 10.0 21.0 ± 3.7 20.3 426.3 ± 8.2
PC1 6.5 ± 0.7 94.6 614.7 ± 115.2
PC2 0.06 ± 0.00
SI: Selectivity index; PC1 (positive control 1): Benznidazole; PC2 (positive control 2): Amphotericin B.
4 Z.U. Din et al.and C-1 and C-5 in 2 are strongly electrophylic because they
are b-enone and due the presence of the electron withdrawing
NO2 group at para position in the aromatic ring. Thus, 1 and 2
can be attacked by the thiols from coenzyme T(SH)2, produc-
ing a T(S)2 – drug covalent complex. This explains the dimin-
ishing of free SH groups in T. cruzi cells after exposed to 1 and
2. The efforts of the cell machinery to regenerate the redox
mediator T(SH)2 may result in disruption of a portion of the
covalent complex, producing an amount of reduced com-
pounds 5 and 6. Usually the reducing agent is NADPH.Please cite this article in press as: Din, Z.U. et al., The structure design of biotransform
parasitic activities. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.In order to check the structural requirements for the activ-
ity of these diarylpentadienones some derivatives reduced at
different positions were prepared by chemical and microbio-
logical methods. Among compounds 3–10 (Fig. 2), 5 and 6
were obtained by bio-catalytic method using whole cells of
P. brasilianum as biocatalyst (Murakami et al., 2013;
Yamaguchi et al., 2011), because all synthetic catalyzing agents
used failed to selectively reduce both double bonds. In P.
brasilianum the enzyme OYE (old yellow enzyme) plays an
important role in the reduction of double bonds.ed unsymmetrical nitro-contained 1,5-diaryl-3-oxo-1, 4-pentadienyls for the anti-
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Table 2 Docking results of compounds 1–10 docked on to
trypanothione reductase (1BZL).
Compounds Binding
energy
(kcal mol1)
Inhibition constant
(Temp = 298.15 k)
ki lM
Calculated
RMS from
reference (A˚)
1 8.51 0.58 32.72
2 10.26 0.03 32.46
3 8.36 0.75 33.70
4 8.96 0.27 26.46
5 7.04 6.90 35.85
6 7.86 1.72 32.75
7 7.50 3.19 27.47
8 8.74 3.92 29.44
9 4.54 473 26.59
10 4.64 396 28.00
The structure design of biotransformed unsymmetrical nitro-contained 1,5-diaryl-3-oxo-1,4-pentadienyls 5T. cruzi and L. amazonensis were treated with 3–10, which
are different reduced form of potent compounds 1 and 2. In
general the IC50 values enhanced significantly for both para-
sites in comparison with values observed for parent com-
pounds (Table 1). It means that double bonds are crucial for
activity. In general it was seen that potency decreases by reduc-
ing any of the moiety of compounds 1 and 2. Compounds hav-
ing one bond reduced (3 and 4) face reduction in the potency
and exhibit IC50 52.2 ± 1.6 and 11.9 ± 0.6 lM against epi-
mastigote. By reduction of the two double bonds we get the
compounds obtained by the metabolomic study, compounds
5 and 6. These compounds also loss their potency and its
IC50 decreases to 58.1 ± 0.9 and 15.3 ± 2.1 lM against epi-
mastigote. Compounds 7 and 8 undergone reduction of car-
bonyl and IC50 reach to >100 and 22.4 ± 1.62 respectively.
Compounds 9 and 10 that were obtained by the reduction of
double bonds and NO2 exhibit a complete loss of potency by
showing IC50 89.8 ± 6.94 and 42.7 ± 4.45 lM respectively.
These results are contrary to those published by others
researchers, who found that nitroreductase enzymes present
in T. cruzi (Wilkinson et al., 2008) and in Leishmania danovani
(Wyllie et al., 2013), but not in the mammal cells, activate
NO2-containing drugs into a more active form. In those organ-
isms, the trypanocidal activity of nitro compounds depends on
nitroreductase enzymes (NTR) that converts them to amines,
enhancing their activity (Hall et al., 2012).
In all the reduced products 3–10 it was observed that com-
pounds derived from 2maintain their activity up to little extent
as compared to that derived from compound 1. By losing
potency the cytotoxicity against normal cell lines improved
and it is also not harmful for it in high concentration. Greater
the selectivity index (SI) value, better the drug candidate. Ben-
znidazole has good SI (94.6) but is still inadequate due to
pathogen resistance (Campos et al., 2014; Mejia et al., 2012)
and its unsatisfactory treatment in the chronic phase of the dis-
ease (Garcia et al., 2005).
The SI value of compound 2 is better than compound 1,
being better candidate than 1. All other reduced products
3–10 show poor selective index as related to their biological
activity. In similar pattern the activity of compounds 3–10 also
shows reduction for L. amazonensis (promastigotes), except for
compound 3, derived from 1, which shows IC50 value c.a. halfFigure 4 Planarity loses as the result of reduction of doub
Please cite this article in press as: Din, Z.U. et al., The structure design of biotransform
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(Table 1).
2.3. Molecular docking
2.3.1. Optimization of ligands
The structure of all compounds 1–10 was analyzed for their
stability and optimized energy using software Avogadro which
is an advanced semantic chemical editor, visualization, and
analysis platform (Hanwell et al., 2012). Theoretical calcula-
tions were carried for best stable structure of compounds.
Lower energy conformers were selected for docking calcula-
tion. It was observed that the planarity of compounds changed
completely by reducing one or more bonds (Fig. 4). Thus, in
case of compounds 3–10, the aromatic rings go out of the
plane, and the molecules gain conformational flexibility. For
activity the planarity stability is crucial, and loss of activity
occurred once the reduction of any moiety occurs.
2.3.2. In silico interaction studies
All compounds were analyzed for their binding possibility to
enzyme trypanothione Pdb code 1BZL and the result obtained
are tabulated in Table 2. Active site calculation was performedle bonds in compound 2, calculated by Avogadro 1.1.1.
ed unsymmetrical nitro-contained 1,5-diaryl-3-oxo-1, 4-pentadienyls for the anti-
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6 Z.U. Din et al.on the basis of crystallized ligand in its crystal structure. Cen-
troid of the active site was calculated and then all compounds
were evaluated for their in silico inhibition study. The amino
acids that contribute actively are Gly-12, Gly-14, Ser-15,
Gly-16, Asp-36, Val-37, Ser-47, Ala-48, Gly-51, Thr-52, Cys-
53, Val-56, Cys-58, Lys-61, Gly-126, Gly-128, Ala-160, Ser-
161, Gly-162, Arg-288, Arg-291, Gly-326, Asp-327, Met-333,
Leu-334, Thr-335, Pro-336, and Ala-338. Compounds 1–10
have interaction with amino acid in the active sites of 1BZL,
and depend on the structure and pharmacophoric sites
(Figs. 5a and 5b). Compound 1, which is second potent com-
pound, has interaction with amino acids Lys-61 by forming
H-bond between Oxygen of nitro having bonded distance
2.5 A˚. H-bond pi interaction between aromatic ring and Gly-
16 by distance of 1.65 A˚ was also observed (Fig. 5a). Com-
pound 2, which is the most potent in the series, shows a good
interaction with amino acids of the active site of enzyme. Sev-
eral bonding interactions were calculated including H bond
between Carbonyl and that of Thr-335 by distance 2.93 A˚,
H-bond between Gly-128 with oxygen of nitro group by dis-
tance of 3.16 A˚, 2H bonds between Thr-335 with oxygen of
nitro group by distance of 2.49 and 3.06 A˚ respectively. Also
1H bond between Gly-51 with oxygen of carbonyl by bonding
distance of 3.40 A˚ along with 1 sigma pi interaction between
Thr-52 and aromatic ring of ligand by distance of 3.4 A˚ were
calculated (Fig. 5a).
Compound 2 and their derivatives have two nitro groups
show greater interaction than compound 1 derivatives having
one nitro group. Extra nitro group significantly increases all
types of interaction including van der Waals, hydrogen bond-
ing, water interaction, electrostatic and covalent bond interac-
tion (Fig. 5a).Figure 5a In silico analysis of the interaction of compou
Please cite this article in press as: Din, Z.U. et al., The structure design of biotransform
parasitic activities. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.Compounds exhibited potency in silico were also active in
wet laboratory experiment such as compounds 1, 2, 3, 4, 6
and 8. The docking result is in agreement with in vitro assay
results except compounds 4 and 8, which show great inhibition
in silico than wet laboratory experiment. Compound 4 having
one bond and compound 8 having carbonyl reduced may
probably give space to enzyme to be interacting more strongly.
After reduction of these moieties it still maintains some degree
of planarity, but when both double bonds are reduced the pla-
narity loses completely. So the interaction forces become weak.
These results showed that there is maximum probability that
these compounds inhibit trypanothione reductase (see Fig. 6).
2.3.3. Studies on molecular orbitals by computational analysis
The highest occupied molecular orbital (HOMO) and lowest
unoccupied molecular orbital (LUMO) for compounds 1 and
2 (Fig. 7), were analyzed by Gaussian (Hehre et al., 1972). It
is observable that HOMO has major contribution mainly
localized on the ring B of compound 1, while on ring A of com-
pound 2 with little charge density on adjacent double bonds.
The energy of HOMO is the ability of a compound to lose elec-
tron, and therefore considered equal to the ionization poten-
tial. While on the other hand, energy of LUMO describes
the ability of a compound to gain electrons. Therefore, the
negative of the energy of LUMO is taken as electron affinity.
The figure shows that compounds 1 and 2 have LUMO contri-
bution on C-1 and C-5, which represent that the double bonds
are more susceptible to reduction so it can be reduced by the
action of enzyme trypanothione reductase (Trypanothione is
potential nucleophile in living cell of Trpanosoma cruzi). More
ever the electron with drawing para nitro group on aromatic
ring A or B makes the double bond more reactive for nucle-nds 1 (above) and 2 (below) with active site of 1BZL.
ed unsymmetrical nitro-contained 1,5-diaryl-3-oxo-1, 4-pentadienyls for the anti-
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Figure 5b In silico analysis of the interaction of compounds 3–10 with active site of 1BZL.
Figure 6 Comparison of compounds 7 and 8 interaction in 2D.
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Figure 7 Electronic distributions for compounds 1 and 2 [(1E,4E)-2-methyl-1,5-bis(4-nitrophenyl)penta-1,4-dien-3-one]. Semi-empirical
calculations were performed using the Gaussian software package with the semi empirical B3LYP/6-31G(d,p) method and full geometric
optimization.
Figure 8 Pro-drugs pharmacophoric moieties.
8 Z.U. Din et al.ophile attack. That’s why when the nitro reduces the activity
diminishes completely. The stability of all compounds was also
calculated by Avogadro (Hanwell et al., 2012).
3. Conclusions
Metabolomic study of potent compounds 1 and 2 discloses interesting
target by their mechanistic study. The action of parasite can modify the
compounds in the result of metabolism. The metabolites obtain afford
the reduction of both double bonds. Our previous study gives insight
that the thiol level decreases once these compounds enter to parasite.
When compounds 1 and 2 were reduced prior to treatment to T. cruzi,
the decrease in potency was observed. So we can conclude that all the
unsaturated moieties act as pharmacophores. We here propose that the
covalent binding of compounds 1 and 2 with low molecular weight thi-
ols as well as with protein thiols is a principal cause of the drug’s tox-
icity against T. cruzi. Fig. 8 summarizes the necessary structural
features for good activities of these diarylpenthadienones. More ever,Please cite this article in press as: Din, Z.U. et al., The structure design of biotransform
parasitic activities. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.to the best of our knowledge this is the first study showing the
reduction of double bonds inside pathogen leading to potent parasitic
activity and best structure–activity relationships in a new class of
anti-parasitics.
4. Experimental
4.1. General
All chemicals were purchased from Organics, Sigma–Aldrich,
Acros Chemicals and Fisher Scientific Ltd and used without
further purification. The deuterated solvents of Apolo were
used for the NMR analysis. Thin layer chromatography was
performed with precoated silica gel G-25-UV254 plates and
detection was carried out at 254 nm under UV, and by vanillin
in H2SO4 solution.
1H NMR, 13C NMR were performed on a
Bru¨ker AVANCE 400 operating at 400.15 MHz anded unsymmetrical nitro-contained 1,5-diaryl-3-oxo-1, 4-pentadienyls for the anti-
arabjc.2016.03.005
The structure design of biotransformed unsymmetrical nitro-contained 1,5-diaryl-3-oxo-1,4-pentadienyls 9100.62 MHz, respectively. CDCl3 was used as solvent and
tetramethylsilane (TMS) as internal reference. Compounds 1,
2 and 3–10 were dissolved in organic solvents at about
5–10 mg mL1 each and shifted into a 5-mm NMR tube.
Chemical shifts (d in ppm) were measured with accuracy of
0.01 (1H) and 0.1 ppm (13C).
4.2. Chemistry
4.2.1. Synthesis of (1E,4E)-2-methyl-1-(4-nitrophenyl)-5-
phenylpenta-1,4-dien-3-one (1)
A Solution of A11K2 (200 mg, 0.976 mmol), and benzalde-
hyde (124 mg, 1.17 mmol) in ethanol (6 mL) was stirred for
5 min at room temperature, added sodium hydro oxide solu-
tion (2 mL, 1.25 mmol) and stirring was continued for six
hours. The solvent was evaporated in vacuo. The residue dis-
solved in ethyl acetate, extracted with NaHSO3 solution and
dried with Na2SO4; solvent was evaporated in vacuo and the
crude product was recrystallized from Ethyl acetate to give
pure 1.
Percent yield: 92%; 1H NMR (400 MHz, CDCl3) d 8.28 (d,
J= 8 Hz, 2H, ArH), 7.73 (d, J= 16 Hz, 2H, ArH), 7.62 (m,
2H, ArH), 7.58 (d, J= 12 Hz, 2H, ‚CH), 7.55 (s, 1H,
CH3C‚CH), 7.42 (m, 3H, ArH), 7.36 (d, J= 16 Hz,
2H, ‚CH), 2.19 (d, J= 4 Hz, 3H, ‚CCH3);
13C NMR
(400 MHz, CDCl3) d 14 (1C, ‚CCH3); 121 (1C, ‚C); 125
(2C, ArC); 128 (2C, ArC); 129 (2C, ArC); 130 (2C, ArC);
131 (1C, ArC); 135 (1C, ‚C); 135 (1C, ‚C); 142 (1C, ArC);
143 (1C, ‚C); 145 (1C, ArC); 147 (1C, ArC); 192 (1C, CO);
HRMS ESI(+): calcd 294.11247; found 294.11339; UV–Vis
kmax (nm)[e (mol
1 dm3 cm1)] in CH2Cl2: 308.4.2.2. Synthesis of (1E,4E)-2-methyl-1,5-bis(4-nitrophenyl)
penta-1,4-dien-3-one (2)
Percent yield: 65%; 1H NMR (400 MHz, CDCl3) d 8.31 (t,
J= 0 Hz, J= 4 Hz, 1H, ArH), 8.29 (t, J= 0 Hz, J= 4 Hz,
2H, ArH), 8.23 (t, J= 0 Hz, J= 4 Hz, 1H, ArH), 7.74 (m,
3H, ArH and CH3AC‚CH), 7.60 (d, J= 8 Hz, 3H, ‚CH
and ArH), 7.49 (d, J= 16 Hz, 1H, ‚CH), 2.21 (d,
J= 1.6 Hz, 3H, ‚CCH3);
13C NMR (400 MHz, CDCl3) d
191, 149, 147, 142, 141, 141, 141, 136, 130, 129, 125, 124,
124, 14; HRMS ESI(+): calcd 339.09955; found 339.09955.
UV–Vis kmax (nm)[e (mol
1 dm3 cm1)] in CH2Cl2: 304.
4.2.3. (E)-2-methyl-1-(4-nitrophenyl)-5-phenylpent-1-en-3-one
(3)
Percent yield: 69%; 1H NMR (400 MHz, CDCl3) d 8.17 (d,
J= 8.8 Hz, 2H), 7.42 (d, J= 8.5 Hz, 2H), 7.38 (s, 1H),
7.27–7.20 (m, 2H), 7.20–7.10 (m, 4H), 3.07 (t, J= 7.8 Hz,
2H), 2.93 (d, J= 7.3 Hz, 2H), 1.98 (d, J= 1.4 Hz, 3H); 13C
NMR (400 MHz, CDCl3) 201, 147, 143, 141, 140, 136, 130,
129, 129, 126, 124, 40, 31, 14.
4.2.4. (E)-2-methyl-1,5-bis(4-nitrophenyl)pent-1-en-3-one (4)
Percent yield: 72%; 1H NMR (400 MHz, CDCl3) d 8.26 (d,
J= 8.8 Hz, 2H), 8.16 (d, J= 8.7 Hz, 2H), 7.52 (d,
J= 8.7 Hz, 2H), 7.50 (s, 1H), 7.41 (d, J= 8.8 Hz, 2H), 3.19
(d, J= 6.7 Hz, 2H), 3.14 (d, J= 6.5 Hz, 2H), 2.06
(d, J= 1.4 Hz, 3H). 13C NMR (400 MHz, CDCl3) d 200,
149, 147, 147, 142, 140, 136, 130, 129, 124, 124, 39, 30, 13.Please cite this article in press as: Din, Z.U. et al., The structure design of biotransform
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Percent yield: 30%; 1H NMR (400 MHz, CDCl3) d 8.09 (d,
J= 8.7 Hz, 2H), 7.25–7.14 (m, 5H), 7.10 (d, J= 6.8 Hz,
2H), 3.06 (dd, J= 13.4, 7.6 Hz, 1H), 2.88–2.73 (m, 4H),
2.69–2.52 (m, 2H), 1.08 (d, J= 7.0 Hz, 3H). 13C NMR
(400 MHz, CDCl3) d 212, 148, 146, 149, 130, 128, 128, 126,
124, 48, 43, 38, 30, 17.
4.2.6. 2-Methyl-1,5-bis(4-nitrophenyl)pentan-3-one (6)
Percent yield: 39%; 1H NMR (400 MHz, CDCl3) d 8.10 (dd,
J= 8.8, 1.1 Hz, 4H), 7.29 (dd, J= 8.8, 3.8 Hz, 4H), 3.09
(dd, J= 13.5, 7.6 Hz, 1H), 3.00–2.81 (m, 4H), 2.71–2.57 (m,
2H), 1.11 (d, J= 7.0 Hz, 3H). 13C NMR (400 MHz, CDCl3)
d 211, 149, 148, 147, 146, 130, 129, 124, 124, 48, 42, 38, 29, 17.
4.2.7. (1E,4E)-2-methyl-1-(4-nitrophenyl)-5-phenylpenta-1,
4-dien-3-ol (7)
Percent yield: 72%; 1H NMR (400 MHz, CDCl3) d 8.10
(d, J= 8.9 Hz, 2H), 7.37–7.30 (m, 4H), 7.29–7.22 (m, 2H),
7.21–7.14 (m, 1H), 6.63 (d, J= 15.1 Hz, 2H), 6.18 (dd,
J= 15.9, 6.7 Hz, 1H), 4.78 (d, J= 6.7 Hz, 1H), 1.85
(d, J= 1.3 Hz, 3H). 13C NMR (400 MHz, CDCl3) d 146,
144, 143, 136, 132, 129, 129, 128, 128, 126, 124, 123.
4.2.8. (1E,4E)-2-methyl-1,5-bis(4-nitrophenyl)penta-1,4-dien-
3-ol (8)
Percent yield: 76%; 1H NMR (400 MHz, CDCl3) d 8.22 (dd,
J= 8.8, 4.2 Hz, 4H), 7.57 (d, J= 8.7 Hz, 2H), 7.47 (d,
J= 8.6 Hz, 2H), 6.84 (d, J= 15.9 Hz, 1H), 6.76 (s, 1H),
6.47 (dd, J= 15.9, 6.0 Hz, 1H), 4.97 (d, J= 5.9 Hz, 1H),
1.97 (d, J= 1.3 Hz, 3H). 13C NMR (400 MHz, CDCl3) d
147, 146, 144, 143, 142, 134, 130, 130, 127, 125, 124, 124, 78,
15.
4.2.9. 1-(4-Aminophenyl)-2-methyl-5-phenylpentan-3-one (9)
Percent yield: 90%; 1H NMR (400 MHz, CDCl3) d 7.28–7.23
(m, 2H), 7.21–7.14 (m, 1H), 7.12 (dd, J= 7.8, 0.9 Hz, 2H),
6.94 (d, J= 8.4 Hz, 2H), 6.73 (d, J= 8.4 Hz, 2H), 2.83
(ddd, J= 10.9, 10.2, 4.7 Hz, 3H), 2.77–2.65 (m, 2H), 2.57
(ddd, J= 17.2, 8.6, 6.4 Hz, 1H), 2.47 (dd, J= 13.4, 7.2 Hz,
1H), 1.03 (d, J= 6.9 Hz, 3H). 13C NMR (400 MHz, CDCl3)
d 214, 143, 141, 131, 130, 128, 128, 126, 116, 49, 44, 39, 30, 16.
4.2.10. 1,5-Bis(4-aminophenyl)-2-methylpentan-3-one (10)
Percent yield: 92%; 1H NMR (400 MHz, CDCl3) d 6.90 (dd,
J= 8.3, 7.1 Hz, 4H), 6.60 (dd, J= 8.4, 1.8 Hz, 4H), 3.62 (s,
4H), 2.83 (dd, J= 13.3, 7.1 Hz, 1H), 2.79–2.59 (m, 4H),
2.58–2.49 (m, 1H), 2.45 (dd, J= 13.4, 7.2 Hz, 1H), 1.02 (d,
J= 6.8 Hz, 3H). 13C NMR (400 MHz, CDCl3) d 214, 144,
144, 131, 131, 130, 129, 115, 115, 48, 44, 38, 29, 16.
4.3. Parasites and cells
L. amazonensis promastigote forms (MHOM/BR/Josefa) were
maintained at 25 C in Warren’s medium (brain heart infusion
plus haemin and folic acid) pH 7.0, supplemented with 10%
Fetal Bovine Serum (FBS, Gibco Invitrogen, Grand Island,
NY, USA). Epimastigote form of T. cruzi (Y strain) was
maintained at 28 C in liver infusion tryptose medium (LIT)
supplemented with 10% inactivated FBS.ed unsymmetrical nitro-contained 1,5-diaryl-3-oxo-1, 4-pentadienyls for the anti-
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The effects of synthesized compounds were evaluated in pro-
mastigotes of L. amazonensis and epimastigotes of T. cruzi.
The inoculum (1  106 cells/mL) was introduced into 24-well
plate containing the compounds dissolved in dimethylsulfoxide
(DMSO) and Warren’s medium or LIT in several concentra-
tions (1.0–100.0 lM). The final concentration of DMSO did
not exceed 1%. Cell grown was determined by counting the
parasites with a Neubauer hemocytometer after incubation
for 72 h at 25 C for L. amazonensis or for 96 h at 28 C for
T. cruzi. The results were expressed as percentage of inhibition
in relation to the control cultured. The IC50 was determined by
logarithm regression analysis of the data obtained. These pro-
cedures were repeated scaling-up the 1 and 2 dosage to reach
IC90 and the medium was lyophilized and further extracted
for metabolomic study.4.5. Cytotoxicity assay
The cytotoxicity was evaluated in VERO cells. For VERO
cells, a suspension of 2.5  105 cells/mL was cultured in
DMEM. After 24 h, the different compounds were added to
each well (10.0–1000.0 lM) and the plates were incubated for
72 h for VERO cells in a 5% CO2–air mixture at 37 C. Fol-
lowing incubation, MTT assay was performed (2 mg/mL stock
solution, 50 lL/well). After 4 h of incubation, the MTT pro-
cessing was stopped, and the formazan crystals were solubi-
lized by adding DMSO (150 lL/well). The relative amount
of formazan/well produced by viable cells was determined
spectrophotometrically at 570 nm by blanking against an
appropriate control. The CC50 values (50% cytotoxic concen-
tration) were estimated and the selectivity index (SI) was used
to compare cytotoxicity between cells and protozoa (ratio:
CC50 of cells divided by CC50 of the compound in the
protozoa).4.6. Docking studies
In order to evaluate the described biological results, com-
pounds 1–10 were evaluated for docking studies against
enzyme trypanothione reductase, which is reported under
pdb code 1BZL. Auto Dock Tool 4.2 from scripts research
institute was used for docking analysis (Morris et al., 2009).
Docking was used to predict both ligand and binding affinity
orientation of ligand to the receptor, to form complex in three
dimensional spaces. Autodock with the inhibition score, which
uses bond strengths, was used for the docking calculations.
Calculation was performed by removing water molecules first
and adding polar hydrogen atoms using the option available
in autodock tool. Gasteiger charges were also assigned for
ligands and then the protein ligand was processed for obtain-
ing file .pdbqt, which are input files for autodock 4.2. Enzyme
1BZL was optimized by considering only chain A and active
site occupied by inhibitors. The protein binding sites were
defined using those occupied by the co-crystallized ligand for
1BZL. The program Accelrys Discovery Studio v4.1
(Dassault Syste`mes BIOVIA, 2015) was used to analyze the
docking results and poses (orientations/conformations) and
interactions.Please cite this article in press as: Din, Z.U. et al., The structure design of biotransform
parasitic activities. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.4.7. Computational study
Calculations were performed using the Gaussian 03 package
(Frisch et al., 2004). Geometries of all the species investigated
were optimized without any symmetry constraints, and the
resulting structures were further assessed using vibrational fre-
quency analysis to probe whether or not the structures repre-
sent true minimum-energy geometries. If any imaginary
frequency was found, further optimizations were performed
along those normal coordinates (without symmetry con-
straints). All the calculations were done using two hybrid
DFT functionals: B3LYP (Parr and Yang, 1989) and
B3PW91 (Parr and Yang, 1989). The approaches are subse-
quently referred to as B3LYP/6-31G*. For all the structures
under investigation, the singlet states were considered for cal-
culation. Molecular structures and frontier orbital’s were visu-
alized using Gauss view software.
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